PCM
SONM icon

Perkins Capital Management’s DNA X Inc SONM Stock Holding History

Perkins Capital Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,011
Closed -$1.49M – 107
2021
Q1 		$1.49M Buy
1,011
+653
+182% +$1.15M 0.86% 41
2020
Q4 		$467K Buy
358
+25
+8% +$27.3K 0.31% 64
2020
Q3 		$466K Buy
+333
New +$535K 0.43% 55

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Perkins Capital Management's SONM Position: Q2 2021 in Review

Perkins Capital Management sold out of DNA X Inc (SONM) in Q2 2021, closing a stake of 1,011 shares — an estimated $1.49M sold.

Perkins Capital Management first reported a position in SONM in Q3 2020 and held it in 3 quarters. The position peaked at $1.49M in Q1 2021. 17 funds tracked by Wall St. Rank hold SONM as of Q2 2021.

  • Perkins Capital Management reported no remaining DNA X Inc position as of Q2 2021 after selling out during the quarter.
  • Perkins Capital Management sold 1,011 DNA X Inc shares in Q2 2021, an estimated $1.49M.
  • Perkins Capital Management first reported a position in DNA X Inc in Q3 2020 and held it in 3 quarters.
  • Perkins Capital Management's DNA X Inc position peaked at $1.49M in Q1 2021.
  • 17 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2021.

Based on Perkins Capital Management's 13F filing for Q2 2021, filed 28 Jul 2021.